Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

DADE BEHRING INC

UEI: L5LWUCMMWU69

DADE BEHRING INC is a federal contractor, registered under UEI L5LWUCMMWU69. It has been awarded $308,000 across 8 federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing and All Other Miscellaneous Ambulatory Health Care Services. Top awarding agencies include Department Of Veterans Affairs and Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

L5LWUCMMWU69

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Veterans Affairs$302.0K98.1%

Department Of Defense$6.0K2%

Awards by NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing$155.0K50.3%

621999 - All Other Miscellaneous Ambulatory Health Care Services$153.0K49.7%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in DADE BEHRING INC's top NAICS codes and agencies

CONTROL, RESPIRATORY PA

Solicitation # SPE2DS-26-T-311F

The BioFire RP2.1/RP2.1plus Control Panel is a synthetic nucleic acid-based quality control product consisting of 12 vials, each containing 300 microliters of a non-infectious buffer solution with stabilizers and preservatives. It is designed for in vitro use with the FilmArray instrument to monitor the detection and identification of respiratory pathogens during RP2.1 panel testing. Each kit provides sufficient reagent for six quality control runs, including six positive and six negative controls. The product requires strict frozenstorage between -25°C and -15°C (-13°F to 5°F) and has a non-extendable shelf life of 18 months, with no more than two months allowed to have passed from the date of manufacture to delivery to the government. Labeling must include the date of manufacture, expiration date, contract number, and lot number in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection against damage, with exterior containers suitable for safe transport at the lowest cost to the specified delivery point. The item is governed by DLA technical and packaging requirements, including RS013 for shelf life, RP001 for packaging standards, and RD003 for potential covered defense information. The National Stock Number is 6550-01-690-4435, with a procurement quantity of three kits under solicitation SPE2DS-26-T-311F, with a delivery deadline of 83 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 8 hours ago

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-308W

The contract is for the procurement of 150,000 units of the QuickVue At-Home OTC COVID-19 Test kit, a rapid antigen detection system designed for self-administration using an anterior nasal swab. Each kit contains all necessary components for two tests, including a tube holder, two prefilled extraction tubes, two swabs, and two test strips with a dipstick format that delivers results in ten minutes through a two-color readout: a blue control line and a red test line. The test is intended for single-user administration, with the two tests in each kit to be performed 24 to 36 hours apart, eliminating the need for additional equipment or laboratory support. Built-in procedural controls ensure test validity, and all materials are pre-assembled for immediate use. The kits are to be delivered within 20 days of award under solicitation SPE2DS-26-T-308W, issued by the Department of Defense’s Medical Supply Chain MD Surg FSF, with performance specified to occur in West Los Angeles, CA. The contract includes adherence to DLA technical and quality requirements under RA001, packaging standards per RP001, and removal protocols for government identification on non-accepted items per RQ011, with the NSN 6550-01-697-6662 identifying the product for federal acquisition purposes.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, GLUCOSE

Solicitation # SPE2DS-26-T-308J

The control set for glucose is designed for use with the Accu-Chek Inform II system and includes two 2.5 mL vials—one each of Level 1 and Level 2 control solutions—to ensure accurate calibration and performance verification of test strips. It must be stored between 39 and 86 degrees Fahrenheit (4 to 30 degrees Celsius) and must not be frozen. The item is issued as a single unit and is subject to strict medical procurement standards, including commercial packaging requirements that ensure protection from damage and safe delivery by common carriers. All units must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and include the date of manufacture, expiration or retest date, contract number, and lot number. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of government delivery. Technical and quality requirements referenced under R and I numbers are governed by the DLA Master List, with revision standards tied to solicitation or award dates depending on acquisition size. This item is classified as a Type I (Code M) medical supply, and all labeling, packaging, and marking must comply with the latest version of MMS1C. The NSN is 6550-01-642-5011, the solicitation number is SPE2DS-26-T-308J, and delivery is required within 20 days after order award to Fort Campbell, with the contract managed by the Department of Defense under the Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Clinical Rotation Placement CoordinationThe contract seeks a subcontractor to secure clinical affiliation agreements and coordinate 10-hour clinical rotations for students at accredited medical facilities near Quantico, VA, ensuring seamless integration of educational requirements with healthcare facility operations. The effort focuses on establishing and maintaining partnerships with approved medical sites to provide hands-on clinical experiences aligned with academic benchmarks, with all placements required to meet accreditation standards and operate within the specified geographic region. The work involves managing logistical coordination, compliance documentation, and ongoing communication between educational institutions and clinical sites to uphold the integrity and safety of student rotations. The solicitation is issued under a subcontract type with a NAICS code of 621999, indicating non-clinical support activities in the healthcare sector, and is managed by the Department of Defense under the Commander designation. Responses are due by August 20, 2026, with the opportunity posted on August 4, 2026. The place of performance is designated as Quantico, VA, with a zip code of 22134, though no specific office address or point of contact is provided. The contract does not indicate any set-aside status or organizational restrictions, leaving the field open to qualified subcontractors capable of delivering reliable clinical placement coordination in the region.

POSTED

DEADLINE

Fisher Scientific Reagents and Consumable Materials for Cell Therapy Manufacturing

Solicitation # 26-008155

The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to Fisher Scientific for validated reagents and consumable materials essential to the manufacturing of FDA-regulated cell-based therapies used in NIH clinical trials. These materials have been rigorously validated and approved by the Center for Cellular Engineering’s Quality Assurance Department to ensure consistent quality, safety, and efficacy in producing cell therapies for patient care. Any substitution of these materials would necessitate extensive and costly revalidation of manufacturing processes, leading to significant delays and potential risks to ongoing clinical trials, making Fisher Scientific the only viable supplier capable of providing the required validated products and supporting documentation compliant with federal regulatory standards. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which allows for single-source procurement when only one provider can meet the government’s specific requirements, and the value does not exceed the simplified acquisition threshold. The product service code is 6550, and the NAICS code is 325413, classifying the items as in-vitro diagnostic substances. Performance will occur at the NIH Clinical Center in Bethesda, Maryland. While this notice does not solicit bids or proposals, responsible parties may submit capability statements by August 13, 2026, at 6:00 p.m. Eastern Time, referencing POTS 26-008155, though the government retains full discretion to proceed without competition. All inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.

National Institutes Of Health Olao

POSTED

DEADLINE

CryoStor® CS10, 100 mL Bags for Cell Therapy Manufacturing

Solicitation # 26-007655

The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to BioLife Solutions for 80 bags of CryoStor® CS10, 100 mL, used exclusively for cryopreserving cell therapy products in FDA-regulated clinical trials. The product is essential to the Center for Cellular Engineering’s manufacturing processes, having been rigorously validated and approved by quality assurance to ensure the safety and consistency of therapies administered to patients. Substituting an alternative cryoprotectant would necessitate extensive revalidation, leading to significant delays, increased costs, and potential disruption to patient care. CryoStor® CS10 is the only commercial cryoprotectant with an FDA Master File and is the only product fully qualified for use in the NIH’s regulated environment, justifying the sole-source designation under FAR 13.106-1(b)(1)(i). The acquisition supports critical clinical research operations at the NIH Clinical Center in Bethesda, Maryland, under PSC 6550 and NAICS 325413. While the notice does not request formal proposals, responsible parties may submit capability statements by August 13, 2026, though the government reserves the right to proceed without competition. All submissions must reference solicitation number 26-007655 and be sent electronically to Shasheshe Goolsby at the NIH Office of Acquisitions and Logistics Management.

National Institutes Of Health Olao

POSTED

DEADLINE

PEO-M Unmanned Surface Vehicle (USV) Poseidon's Fury Collaboration Event (CE)

Solicitation # PEO_M_USV_Poseidon_s_Fury_CE

SOFWERX and the USSOCOM Program Executive Office Maritime (PEO-M) are hosting the Poseidon’s Fury Collaboration Event to accelerate the development of the Unmanned Surface Vehicle Mission-Aligned Reference Architecture (MARA), a standards-based framework designed to improve interoperability across Joint Force manned and unmanned maritime systems while eliminating redundant, service-specific platform development. This initiative is open exclusively to U.S. persons and involves a two-phase process beginning with a virtual collaboration event on August 26, 2026, where SOF operators and industry partners will engage in breakout sessions to define operational needs around user interface, autonomy, command and control, and platform effectiveness. Participation in this event is optional but strongly encouraged to align solutions with warfighter requirements, with registration closing August 14, 2026. Those who do not attend the CE may still submit capabilities for consideration during the Assessment Event, which opens on September 14, 2026, and closes October 2, 2026. A virtual Q&A session is available on September 23 for clarification on technical expectations. Selected submissions will undergo a downselect process, with winners invited to participate in a comprehensive on-water Assessment Event at Stennis Space Center, Mississippi, between November 2 and 20, 2026. Participants must demonstrate their USV capabilities in real-world conditions, with evaluations conducted by Subject Matter Experts from USSOCOM, JHU APL, WARCOM, and MARSOC using predefined technical and operational criteria. Successful performers may be transitioned to Phase 5, where potential pathways for follow-on acquisition include Other Transaction Authorities (OTAs) under 10 U.S.C. §4022, research agreements under 15 U.S.C. §3715, cooperative R&D agreements, experimental procurement under §4023, or prize competitions—potentially leading to non-competitive production awards based on successful prototype outcomes. All awardees must comply with NIST SP 800-171 for securing Controlled Unclassified Information, and eligibility is limited to U.S. persons and organizations capable of supporting USSOCOM’s unique maritime missions.

Department Of Defense

POSTED

DEADLINE

CHIP, HYDROGEN PEROX

Solicitation # SPE2DS-26-T-300S

The contract under solicitation SPE2DS-26-T-300S is for the procurement of one unit of CHIP, HYDROGEN PEROXIDE for use with a CMS analyzer, featuring ten measurement capillaries filled with a substance-specific reagent detection system calibrated to a measuring range of 0.20–2.0 ppm and capable of conducting ten tests. The procurement is managed by the Defense Logistics Agency under the Department of Defense, with a response deadline of August 10, 2026, and a posted date of August 3, 2026. Delivery is required at Camp Carroll, Waegwan, Korea, under FOB Destination terms, with the item to be delivered within 84 calendar days of the request issue date, resulting in an anticipated delivery window ending around October 27, 2026. The contract specifies a fixed-price structure with no option quantities indicated, and while individual unit pricing is listed at $122.00, the total contract value cannot be determined due to incomplete pricing details. Compliance with stringent packaging and marking standards is mandatory, governed by MIL-STD-2073-1E and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items. Labels must include the date of manufacture, expiration or retest date, contract number, and lot number, with hazardous material labeling adhering to the Hazard Communication Standard and specific submission requirements for hazard warning labels and material safety data sheets prior to award. The contractor must use Wide Area WorkFlow for electronic invoicing and receiving reports, and the government conducts all inspection and acceptance at the delivery point. Numerous FAR and DFARS clauses are incorporated, including those on employment eligibility verification, combating human trafficking, sustainable products, safeguarding contractor information systems, and NIST SP 800-171 compliance, some with deviations allowing for modified application. Offerors must hold a valid Unique Entity ID and CAGE code, submit socioeconomic status representations, and disclose any covered defense telecommunications equipment or joint venture partnerships. All proposals must be submitted electronically via DIBBS, and no physical attachments or formal evaluation factors are specified beyond implicit Low Price Technically Acceptable considerations typical of simplified acquisitions.

Defense Logistics Agency

POSTED

DEADLINE

Linear Accelerator Integration and QA VerificationThe contract requires the configuration of a quality management system to interface with linear accelerators, ensuring seamless data transfer and verified connectivity, with active support from medical physics staff to validate system performance. This work is critical for maintaining regulatory compliance and ensuring accurate, reliable operation of radiation therapy equipment within a clinical environment. The contractor must implement and test integration protocols that align with clinical standards and safety requirements, addressing potential communication gaps between the quality management system and medical devices. The solicitation is classified as a subcontract under NAICS code 621999, issued by the Department of Veterans Affairs through the 255-NETWORK Contract Office 15, with performance location specified in Kansas City, Missouri, at zip code 64128. The opportunity was posted on August 3, 2026, with a response deadline of August 10, 2026, at 4:00 PM. There is no set-aside designation applied, and no point of contact information is provided. All submissions must meet technical specifications outlined in the solicitation and demonstrate capability to deliver validated, production-ready system integration under the guidance of medical physics professionals.

255-NETWORK Contract Office 15 (36C255)

POSTED

DEADLINE

Small Business & Socioeconomic Participation CoordinationThe contract seeks certified small businesses to act as subcontractors or joint venture partners in support of socioeconomic objectives tied to a future formal solicitation by the Department of Homeland Security’s Science and Technology Acquisition Division. Participation is intended to help meet federal goals for small business involvement in government contracting, with the NAICS code 621999 indicating non-specific medical services or related support activities. Interested parties must respond by September 2, 2026, to be considered for potential inclusion in upcoming procurement opportunities. While no specific solicitation number or place of performance has been identified yet, the opportunity is open to certified small businesses seeking to align with the agency’s socioeconomic participation strategy. Participation does not guarantee a contract award but positions the entity to be considered when future requirements are formally released.

Sci Technology Acq Division

POSTED

DEADLINE

Community Health & Wellness InitiativesThe contract titled Community Health & Wellness Initiatives seeks to establish a subcontract aimed at enhancing community well-being through targeted health education, nutrition workshops, mental health support groups, fitness classes, and preventive care outreach programs. These activities are designed to promote long-term public health outcomes by empowering residents with knowledge and resources to make healthier lifestyle choices and access essential services. The initiative is aligned with the NAICS code 621999, indicating a focus on other miscellaneous ambulatory health services, and operates under the Procurement Services Unit of the City of Hartford, Connecticut. Interested parties must submit responses by the deadline of August 21, 2026, at 8:00 PM Eastern Time, following the posting date of August 3, 2026. This opportunity is structured as a subcontract, suggesting the selected entity will work under a prime contractor or existing program framework to deliver services directly within the Hartford community. While specific performance locations and point of contact details are not provided, the scope emphasizes community-based delivery without geographic restrictions within the state. The contract reflects a proactive approach to addressing health disparities through accessible, localized interventions focused on prevention and holistic wellness.

Procurement Services Unit Department of City of Hartford

POSTED

DEADLINE

KIT, PERFORMANCE QUALIF

Solicitation # SPE2DS-26-T-296S

The contract is for the procurement of a single performance qualification kit for electrochemiluminescence (ECL) testing, specifically designed for use with the MSD PR2 Model 1800 instrument. Each kit includes ten plates and corresponding reagents and is classified as a Type I, Code H item with a strict 12-month non-extendable shelf life. The item is regulated by the FDA and must be supplied with full manufacturer and part number disclosure for verification by the contracting officer. Packaging and labeling must strictly follow Medical Marking Standard No. 1, which replaces all references to MIL-STD-129 for medical acquisitions, and all units must be sealed in commercial-grade containers that prevent damage and breakage during transport. Packaging must comply with MIL-STD-2073-1E, and palletization must adhere to DLA Packaging Requirements for Procurement (RP001). The delivery is FOB destination, with the primary delivery location at APO AP 96278-2060 and an alternative freight address at Osan Air Base, South Korea. The item must be delivered within 20 days of solicitation issuance, with an original required delivery date of August 4, 2026, and no quantity variance is permitted. Payment must be processed through Wide Area WorkFlow, and electronic submission of receiving reports is mandatory. The contract incorporates multiple FAR and DFARS clauses related to cybersecurity, safeguarding covered defense information, prohibition of certain foreign telecommunications equipment, hazardous material handling, subcontracting, inspection at destination, and compliance with whistleblower and compensation reporting requirements. Offerors must possess and provide a Unique Entity Identifier (UEI) and CAGE code and are required to represent their size status and socioeconomic certifications, though no such disclosures are completed in the solicitation. All technical and quality requirements referenced are drawn from the DLA Master List of Technical and Quality Requirements, and the contract remains subject to all applicable defense regulations and compliance standards.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-296T

The contract specifies the procurement of Abbott BinaxNOW COVID-19 Antigen Self Tests for over-the-counter, at-home use, with a total quantity of five cases, each containing twelve kits and two tests per kit. Each kit must be stored between 2 and 30 degrees Celsius and must have a shelf life of exactly twelve months from the date of manufacture, with no extension permitted. No more than one month may have passed between the date of manufacture and the date of delivery to the government. All packaging must conform to commercial standards and the Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129. Labels on every unit must clearly display the date of manufacture, expiration or retest date, and the contract or lot number. The items must be packed in sealed unit containers that protect against damage and shipped in suitable exterior containers to ensure safe, cost-effective delivery to the designated FPO address. Technical and quality requirements referenced in the DLA Master Listapply, and the procurement is subject to defense information handling protocols. The contract was issued under solicitation SPE2DS-26-T-296T with a response deadline of August 10, 2026, and requires delivery within twenty days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, GLUCOSE

Solicitation # SPE2DS-26-T-295F

The contract specifies the procurement of 8 units of Prodigy Blood Glucose Control Solution High Level 2, a medical solution designed to ensure accurate blood glucose testing with Prodigy monitoring systems. Each unit contains 4 milliliters of solution and must meet strict technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, including compliance with packaging, labeling, and marking regulations per Medical Marking Standard No. 1, which supersedes MIL-STD-129. The product must be packaged in sealed unit containers and shipped in commercial exterior containers suitable for safe delivery via common carrier at the lowest rate to Fort Hood, Texas, with all labeling including the date of manufacture, expiration date, contract number, and lot number in accordance with MMS1C. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months; no more than four months may have elapsed from the date of manufacture to the date of government delivery. Storage requirements mandate temperatures between 36° and 86° Fahrenheit (2° to 30° Celsius) with no freezing. The solicitation, issued under SPE2DS-26-T-295F, requires bidders to clearly specify the source and part number of the supplied goods, with a response deadline of August 10, 2026, and delivery expected within 20 days after award. The procurement is managed by the Department of Defense’s Medical Supply Chain, with Mary-Kathryn Donahue as the primary point of contact.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMI

Solicitation # SPE2DS-26-T-297Y

This contract specifies the procurement of CONTROL, BLOOD CHEMISTRY reagent Level 2, intended for use with the i-STAT PT PLUS cartridge on the i-STAT 1 blood gas analyzer, primarily for coagulation testing. The product is supplied in a box of ten 1.0 mL units and must comply with strict technical and packaging standards, including adherence to Medical Marking Standard No. 1, which replaces MIL-STD-129. The item requires refrigerated storage between 2°C and 8°C (36°F to 46°F) and must not be frozen. The reagent has a non-extendable shelf life of 12 months, with no more than one month allowed to have elapsed from the date of manufacture to the date of government delivery. All packaging must include clear labeling of the date of manufacture, expiration or retest date, contract number, and lot number, in accordance with the latest revision of MMS1C. Packaging must meet commercial standards to ensure safe transport by common carrier at the lowest cost, and all items must be properly sealed and protected from damage. The solicitation number is SPE2DS-26-T-297Y, with a response deadline of August 10, 2026, and delivery must occur within five days of award. The NSN is 6550-01-725-6872, and bidders must clearly identify the source and part number of the supplied item.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

AED and Life Safety Equipment InspectionThe contract requires regular inspection, battery checks, and maintenance of automated external defibrillators and other life safety equipment to ensure they remain fully operational and compliant with regulatory standards. Work must be performed consistently to guarantee readiness in emergency situations, with a focus on reliability and adherence to established protocols for medical device upkeep. The scope includes proactive servicing to prevent failures and maintain compliance with state and federal life safety requirements. This subcontract is issued by the State of Rhode Island under the NAICS code 621999 and was posted on August 1, 2026, with responses due by August 26, 2026. The performance location is within Rhode Island, though specific city or zip details are not provided. The contract offers no set-aside designation, and all interested parties must submit their proposals through the state’s vendor bidding portal by the stated deadline. While no point of contact is listed, all inquiries and submissions should be directed via the official state procurement website.

State of Rhode Island

POSTED

DEADLINE

Tuberculosis (TB) Control and Treatment ServicesThe contract aims to enhance tuberculosis control and treatment systems by strengthening diagnosis, treatment, and contact tracing processes in alignment with national health programs, while integrating services with HIV care to ensure a coordinated response. It focuses on building robust public health infrastructure to improve early detection, timely intervention, and effective follow-up for TB cases and their contacts, with an emphasis on efficiency and equity in service delivery. The initiative is designed to support broader public health goals by leveraging existing frameworks and ensuring synergy between TB and HIV service platforms. This is a subcontract under the Centers for Disease Control and Prevention, part of the Department of Health and Human Services, with a posting date of July 31, 2026, and a response deadline of August 31, 2026. The North American Industry Classification System code for this opportunity is 621999, indicating it relates to other ambulatory health care services. The place of performance and specific office address are not provided, suggesting the work may be implemented across multiple jurisdictions or regions as determined by the agency. The contract seeks qualified entities capable of scaling evidence-based interventions and aligning activities with national priorities for disease control and integrated health service delivery.

Centers For Disease Control-Ghc

POSTED

DEADLINE

HIV Prevention and Treatment Program ImplementationThe contract seeks to design and deliver comprehensive HIV prevention, testing, and treatment services targeting key populations across Central America, with a strong emphasis on integration into existing national health systems to ensure sustainability and scalability. The program will prioritize local ownership by building the capacity of community-based organizations and public health entities, fostering partnerships that enable long-term program continuity beyond external support. Services must be culturally appropriate, evidence-based, and tailored to the specific needs of populations most vulnerable to HIV, including but not limited to men who have sex with men, sex workers, transgender individuals, and people who inject drugs. Deliverables include the development and implementation of service delivery models that align with regional public health priorities, data collection and reporting mechanisms to monitor outcomes, and strategies to strengthen health system resilience. All activities must comply with global best practices and local regulatory frameworks while promoting equitable access and reducing stigma. The subcontract is open to qualified organizations capable of executing complex public health initiatives in fragile or under-resourced settings, with a deadline for responses set for August 31, 2026, under the NAICS code 621999 for other miscellaneous ambulatory health care services. The contracting agency is the Centers for Disease Control and Prevention under the Department of Health and Human Services, though no specific office address or point of contact is provided in the posted details.

Centers For Disease Control-Ghc

POSTED

DEADLINE